Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0000947871-17-000255

Director bought 1,190,476 shares at $4.20 ($4,999,999)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ORBIMED ADVISORS LLC Director 2017-03-27 Purchase +1,190,476 $4.20 $4,999,999 6,149,377 I: show line 1 in the form
Open-market purchases · 1,190,476 sh · avg $4.20 · $4,999,999
Loading xslF345X03/ss36710_4.xml…